MINNEAPOLIS–(BUSINESS
WIRE)–Lake Region Medical, a global development and manufacturing
partner to leading medical device companies, will highlight its original
development manufacturing capabilities, services and technologies at the 23rd
annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in
San Francisco, CA, at the Moscone Center. Lake Region
will provide an overview of the clinical applications for its products,
turn-key outsourcing solutions and emerging areas of research and development
for wire-based technologies. Several new research and development initiatives
include electromechanical and sensor-based wire technologies that help to
position Lake Region Medical at the forefront of emerging wire-based delivery
platforms.

“As a leader in wire-based device technologies, Lake Region
is committed to value-added research and development, using internally
developed and licensed intellectual property, that addresses emerging clinical
needs,” said Jim Mellor, Vice President of Marketing and Sales at Lake Region.
“As always, we also continue to work in partnership with our medical device
customers to meet their own contract development and manufacturing needs. With
expertise in five key markets-Stimulation Therapy, Cardiovascular/Structural
Heart, Peripheral Vascular, Neurovascular and Diagnostic Vascular Access-we
look forward to conversations with our customers and clinicians at TCT about
how we can add value at any stage of taking the product concept through to
commercialization.”

Lake Region Medical will focus on the following topics at
TCT, booth # 1405:

NEW! Fortress™ Dielectic Coating

FORTRESS™ is a new coating technology that provides dielectric coating
properties while ensuring superior durability, maximized flex-life, and
reliable long-term electrical insulation. Lake Regions
proprietary coating process and stringent manufacturing specifications ensure
that the coated component is consistently surrounded with an insulating
coating. This is particularly applicable to conductor wire coils where the
FORTRESS Coating provides increased durability over the traditional extrusion
or sheath-type insulation barriers that can have high stress fracture rates
during coil winding.

SMART™ Wire Technologies Research & Development
Initiative

SMART™ Wire Technologies – standing for Sensing, Measuring, Analyzing,
Responding, and Transmitting – are part of Lake Regions strategic initiative
to both partner with existing companies and to independently develop the
capabilities to incorporate sensors and other electrically active components on
its guidewire platforms to maximize the delivery of biometric information to
clinicians while delivering Lake Region’s proven guidewire handling and
performance characteristics.

Advanced Core Wire Technology for Superior Torque Control

Side-by-side comparison of TWISTER™ against traditional torque technology

Lake Region will conduct
live demonstrations that provide a side-by-side comparison of TWISTER Core Wire
Technology against traditional torque technology. The demonstration includes:

• An overview of guidewire construction.
• Clinical considerations for guidewire selection and use.
• Hands-on session with one of Lake Regions
  vascular models.

About Lake Region Medical

Lake Region Medical is a global leader
in the development and manufacture of OEM devices, supplying the worlds
largest medical device companies with minimally invasive delivery solutions. It
is an industry expert in developing and marketing medical devices to meet
unique clinical challenges for cardiovascular, stimulation therapy,
neurovascular, and peripheral vascular applications, and serves all major
markets worldwide. Lake
Region collaborates with
top physicians and leading university research facilities on new product
developments and has established development and distribution partnerships with
industry leading medical device companies throughout the world.

Based on the changing dynamics of the U.S. healthcare
industry, LRM remains well positioned to provide strategic R&D partnership
opportunities with major medical device companies, including:

• Increased investment in R&D to support customers in
  development of non-core devices.
• It is a Preferred Vendor for leading OEMs.
• It offers Innovative IP opportunities unique to the market.
• It develops leading products and technology platforms with
  competitive advantages.

The privately held company, based in suburban Minneapolis MN,
was founded in 1947.